Reducing mortality in individuals at high risk for advanced melanoma through education and screening - 20/10/11
, Susan M. Swetter, MD b, Susan Oliveria, ScD c, Stephen Dusza, DrPh c, Allan C. Halpern, MD, MS c
Reprint requests: Alan C. Geller, MPH, RN, Department of Society, Human Development, and Health, Harvard School of Public Health, Kresge Building, 677 Huntington Avenue, Room 718, Boston, MA 02115.Abstract |
Incidence and mortality rates of melanoma throughout most of the developed world have increased in the past 25 years. We propose that reduction of deaths from melanoma can be best enhanced by strong collaborations between experts in dermatology, primary care, oncology, cancer education and health systems research, epidemiologists, and behavioral scientists, among others. Public and professional educational campaigns should be guided by an understanding of 3 underlying but overlapping roots: epidemiology and preventable mortality (an understanding of who is most likely to be given the diagnosis of thick or late-stage melanoma), biology (an investigation of tumor types that are relatively common but potentially most lethal), and sociology (an analysis of the changes needed in social structures to improve access to those most in need of early detection programs). We review these major concepts, concentrating on the key risk factors for advanced melanoma.
Le texte complet de cet article est disponible en PDF.Key words : early detection, education, melanoma, physician, screening, skin cancer
Abbreviations used : AAD, CI, NM, OR, QALY, SES, SSE, SSM
Plan
| Publication of this supplement to the JAAD was supported by the Division of Cancer Prevention and Control, Centers for Disease Control and Prevention (CDC). |
|
| Conflicts of interest: None declared. |
|
| The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions, recommendations, or official position of the journal editors or the Centers for Disease Control and Prevention. |
Vol 65 - N° 5S1
P. S87.e1-S87.e9 - novembre 2011 Retour au numéro
Article précédent
- Melanoma survival in the United States, 1992 to 2005
- Lori A. Pollack, Jun Li, Zahava Berkowitz, Hannah K. Weir, Xiao-Cheng Wu, Umed A. Ajani, Donatus U. Ekwueme, Chunyu Li, Brian P. Pollack
- Effect of the staging schema on melanoma cancer reporting, 1999 to 2006
- Sue-Min Lai, Jessica B. King, Sarma Garimella, John Keighley, Mary Lewis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?